| Literature DB >> 22852090 |
Abstract
A consumer satisfaction study was conducted to examine the effectiveness on hangover of After-Effect(©), a new food supplement dedicated to improve well-being after an occasion of alcohol consumption. N = 113 persons were invited to participate in a home-based open label study to test the effectiveness of After-Effect(©). On a night when they intended to consume alcohol, three pills were taken before alcohol consumption and two pills afterwards, before going to bed. The following day, participants completed a survey on the amount of alcohol consumed, hangover symptom severity, and satisfaction of the product. N = 103 participants completed the study. 88% of participants reported After-Effect(©) to be effective in reducing alcohol hangover. After-Effect(©) significantly improved overall hangover severity, and all individual hangover symptoms, except for palpitations. In addition, a significant reduction (P = 0.0001) in the severity score on concentration problems was reported when using After-Effect(©). No gender differences were observed, and there was no relationship with the number of alcoholic drinks that were consumed. Consumers were satisfied with the product. In conclusion, consumer satisfaction and hangover severity scores suggest that After-Effect(©) may be effective in reducing alcohol hangover. However, controlled, double-blind clinical trials should confirm these findings.Entities:
Year: 2012 PMID: 22852090 PMCID: PMC3407600 DOI: 10.1155/2012/617942
Source DB: PubMed Journal: Adv Prev Med
Figure 1Number of visits on a French website for alcohol hangover (http://gueuledebois.info/). Data are shown from October 1st 2011 to January 2nd 2012. Each peak corresponds to a Sunday. Note the large peak at New Years day. The peak at November 1st corresponds to the day after Halloween (31 October). Data were obtained via Google Analytics.
Figure 2After-Effect©: package and capsules. Three capsules should be taken before alcohol consumption and two additional capsules before going to bed.
Rationale for the ingredients included in After-Effect©.
| Ingredients | Dose1 | Effect | Improved symptoms2 | Reference |
|---|---|---|---|---|
| Borago seeds oil (22% GLA) | 1500 mg | Precursor of prostaglandin1 | Headache, laziness, being tired | [ |
| Magnesium | 56.25 mg | Might be deficient | Withdrawal symptoms | [ |
| Headaches | [ | |||
| B6 vitamin | 2 mg | Role in immune system | Uncomfortable feeling | [ |
| B1 vitamin | 4.2 mg | Might be deficient | Impatience, restlessness | [ |
| C vitamin | 120 mg | Antioxidative properties | — | [ |
| Fish oil (18% EPA, 12% DHA) | 157.5 mg | Anti-IL1 effect | — | [ |
| Pro-inflammatory cytokines↓ | — | [ | ||
|
| 80 mg | Hepatoprotective properties | — | [ |
|
| 60 mg | Anti-oxidative properties | — | [ |
1Total dose of 5 capsules. 2Only those symptoms that showed a significant improvement during alcohol hangover are listed. GLA: gamma-linolenic acid, EPA: eicosapentaenoic acid (EPA), and DHA: docosahexaenoic acid.
Hangover symptom scores when treated with After-Effect©, and expected scores if After-Effect© had not been used (N = 103).
| Hangover symptom | After-Effect© | No treatment | Significance |
|---|---|---|---|
| Mean (SD) | Mean (SD) | ||
| Thirst | 3.96 (2.5) | 6.62 (2.4) |
|
| Tired | 4.34 (2.6) | 6.96 (2.0) |
|
| Headache | 2.71 (2.5) | 6.42 (2.5) |
|
| Dizziness | 1.34 (2.0) | 3.35 (2.9) |
|
| Loss of appetite | 1.79 (2.3) | 4.39 (3.1) |
|
| Stomachache | 1.60 (2.2) | 4.57 (3.2) |
|
| Nausea | 1.50 (2.1) | 4.81 (3.0) |
|
| Heart racing | 1.20 (1.9) | 2.97 (2.9) |
|
| Global hangover severity | 2.51 (2.0) | 6.54 (2.6) |
|
| AHS total (mean) score | 2.33 (1.6) | 5.18 (1.9) |
|
Scores range from 0 (absent) to 10 (extreme). Differences are significant if P < 0.05.
Figure 3Severity of concentration problems with and without using After-Effect©.
Figure 4Overall hangover severity and total alcohol consumption.
Reported consumer satisfaction on the efficacy of After-Effect© to reduce hangover symptoms.
| Hangover symptom | After-Effect© not effective ( | After-Effect© effective ( | ||||
|---|---|---|---|---|---|---|
| After-Effect© helps? | After-Effect© | No treatment | After-Effect© | No treatment | ||
| No | Yes | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
| Thirst | 27.2% | 72.8%∗ | 6.4 (1.5)† | 6.8 (1.7) | 3.6 (2.4)‡ | 6.6 (2.5) |
| Tired | 28.2% | 71.8%∗ | 6.3 (2.5)†‡ | 7.4 (1.4) | 4.1 (2.5)‡ | 6.9 (2.0) |
| Headache | 18.4% | 81.6%∗ | 5.1 (2.7)† | 6.5 (3.0) | 2.4 (2.3)‡ | 6.4 (2.4) |
| Dizziness | 29.1% | 70.9%∗ | 2.9 (3.1)†‡ | 3.7 (3.5) | 1.1 (1.7)‡ | 3.3 (2.9) |
| Loss of appetite | 38.8% | 61.2%∗ | 4.1 (3.1)† | 4.6 (3.4) | 1.5 (2.0)‡ | 4.4 (3.1) |
| Stomach ache | 31.1% | 68.9%∗ | 3.1 (2.9)†‡ | 5.1 (3.1) | 1.4 (2.0)‡ | 4.5 (3.3) |
| Nausea | 23.3% | 76.7%∗ | 3.8 (3.3)†‡ | 5.3 (3.4) | 1.2 (1.7)‡ | 4.7 (3.0) |
| Heart racing | 42.7% | 57.3% | 2.2 (2.8) | 2.6 (3.1) | 1.1 (1.7)‡ | 3.0 (2.9) |
| Global hangover severity | 13.6% | 86.4%∗ | 5.1 (2.7)† | 6.0 (2.5) | 2.2 (1.6)‡ | 6.6 (2.6) |
| Mean AHS score | 4.3 (1.9)†‡ | 5.3 (2.0) | 2.1 (1.4)‡ | 5.2 (1.9) | ||
| Concentration problems | 34.0% | 66.0%∗ | 5.3 (2.2)† | 5.8 (2.6) | 1.3 (1.7)‡ | 4.4 (3.1) |
Significant differences (P < 0.05) in percentages of subjects who reported After-Effect© is effective or not are indicated by ∗.
Significant differences (P < 0.05) in hangover symptom severity after using After-Effect© or no treatment is indicated by ‡.
Significant differences (P < 0.05) in hangover symptom severity between subjects who reported After-Effect© is effective or not are indicated by †.